{"id":"F2007L03598","name":"Therapeutic Goods Order No. 75 - Standard for Haematopoietic Progenitor Cells Derived from Cord Blood (01/08/2007)","slug":"therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":69925,"registerId":"commonwealth-F2007L03598-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"THERAPEUTIC GOODS ACT 1989","sectionType":"part","heading":"THERAPEUTIC GOODS ACT 1989","content":"# THERAPEUTIC GOODS ACT 1989","sortOrder":0},{"sectionNumber":"THERAPEUTIC GOODS ORDER NO. 75","sectionType":"part","heading":"THERAPEUTIC GOODS ORDER NO. 75","content":"# THERAPEUTIC GOODS ORDER NO. 75\n\nSTANDARD FOR HAEMATOPOIETIC PROGENITOR CELLS DERIVED FROM CORD BLOOD\n\nI, DAVID GRAHAM, delegate of the Minister for Health and Ageing for the purposes\n\nof section 10 of the Therapeutic Goods Act 1989 and acting under that section, having\n\nconsulted with the Therapeutic Goods Committee in accordance with subsection 10(4)\n\nof that Act, HEREBY:\n\n1\\. REVOKE Therapeutic Goods Order No 73 “Standards for haematopoietic progenitor cells derived from cord blood” (TGO73) made on 8th June 2005; and\n\n2. DETERMINE that the matters specified in this Order constitute a standard for haematopoietic progenitor cells derived from cord blood.\n\nIn this order:\n\nDefinitions\n\n“haematopoietic progenitor cells” means primitive pluripotent haematopoietic cells\n\ncapable of self-renewal as well as maturation into any of the haematopoietic lineages,\n\nincluding committed and lineage-restricted progenitor cells;\n\n\"cord blood\" means blood collected from human placental and umbilical cord blood vessels;\n\n  \n\nStandards and requirements:\n\nHaematopoietic progenitor cells derived from cord blood\n\n1.  Haematopoietic progenitor cells derived from cord blood must meet the requirements of the document entitled \"International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection, and Release\" Third edition, dated December 2006, published by the Foundation for the Accreditation of Cellular Therapy and NetCord.\n\nThis Order commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nDated this first day of August 2007\n\nDavid Graham\n\nDelegate of the Minister for Health and Ageing","sortOrder":1}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1777},"content_quality":"ok","complexity_score":3,"scope_assessment":{"changed":false,"description":"This Order is a direct replacement of TGO73 (2005), maintaining the same regulatory scope: ensuring quality standards for cord blood used therapeutically. The update merely adopts the newer version of the international standards (2006 edition) without expanding the subject matter beyond haematopoietic progenitor cells derived from cord blood."},"complexity_factors":["Incorporation by reference of external technical standards (FACT-NetCord 3rd Edition, 2006)—users must locate and interpret a separate document","Scientific terminology requiring specialized medical knowledge (e.g., 'pluripotent haematopoietic cells', 'lineage-restricted progenitor cells')","Minimal structural complexity—only 2 defined terms and a single operative requirement"],"plain_english_summary":"This Order sets safety and quality rules for cord blood banking in Australia—covering blood collected from placenta and umbilical cord—and requires facilities that collect, process, test, bank or release haematopoietic progenitor cells for transplant to follow the international FACT‑NetCord standards (Third Edition, Dec 2006). It applies to cord blood banks, hospitals and labs involved in therapeutic use, ensuring internationally consistent safety for patients; it replaces TGO73 (2005)."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0","history":"/api/acts/therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0/history","analysis":"/api/acts/therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0/analysis","conflicts":"/api/acts/therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0/conflicts","importantCases":"/api/acts/therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0/important-cases","documents":"/api/acts/therapeutic-goods-order-no-75-standard-for-haematopoietic-progenitor-cells-derived-from-cord-blood-0/documents"}}